Cargando…

SLC7A5 act as a potential leukemic transformation target gene in myelodysplastic syndrome

OBJECTIVE: Myelodysplastic syndromes (MDS) are a heterogenous group of clonal hematopoietic stem cell disorders characterized by increased risk of leukemic transformation. This study identifies microRNAs(miRNA) and miRNA targets that might represent leukemic transformation markers for MDS. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Yan, Song, Jing, Chen, Bobin, Xu, Xiaoping, Lin, Guowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872733/ https://www.ncbi.nlm.nih.gov/pubmed/26657287 http://dx.doi.org/10.18632/oncotarget.6512

Ejemplares similares

Predicting leukemic transformation in myelodysplastic syndrome using a transcriptomic signature
por: Guo, Chao, et al.
Publicado: (2023)

FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome
por: Schieber, Michael, et al.
Publicado: (2020)

Inflammation-related genes S100s, RNASE3, and CYBB and risk of leukemic transformation in patients with myelodysplastic syndrome with myelofibrosis
por: Hong, Minghua, et al.
Publicado: (2021)

Fatal right‐sided heart failure due to leukostasis in a patient with leukemic transformation of myelodysplastic syndrome
por: Pryds, Kasper, et al.
Publicado: (2018)

Aberrant Expression of EZH2 in Pediatric Patients with Myelodysplastic Syndrome: A Potential Biomarker of Leukemic Evolution
por: de Souza Fernandez, Teresa, et al.
Publicado: (2019)

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression
por: van Spronsen, Margot F., et al.
Publicado: (2023)

WHO-defined ‘myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations
por: Patnaik, M M, et al.
Publicado: (2010)

Sesamin Acts as Anti-leukemic Compound Interacting with Novel Phosphoprotein Targets and Inducing Apoptosis in Leukemic Cells
por: Wannapruk, Pattharin, et al.
Publicado: (2022)

Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes
por: Gaymes, Terry J, et al.
Publicado: (2021)

Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment
por: Nachef, Marianna, et al.
Publicado: (2021)

Immune dysregulation and potential targeted therapy in myelodysplastic syndrome
por: Zhang, Xiaoying, et al.
Publicado: (2023)

Renal Leukemic Infiltration Overlapping Acute Focal Bacterial Nephritis during Myelodysplastic Syndrome: An Autopsy Case Report
por: Murakami, Keishu, et al.
Publicado: (2022)

Transformation of myelodysplastic syndrome to mixed phenotype acute leukaemia
por: Do, Louis, et al.
Publicado: (2020)

EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism
por: Ramamoorthy, Senthilkumar, et al.
Publicado: (2020)

Bioinformatics gene analysis of potential biomarkers and therapeutic targets of osteoarthritis associated myelodysplastic syndrome
por: Xin, Peicheng, et al.
Publicado: (2023)

Germline SAMD9 Mutation in Siblings with Monosomy 7 and Myelodysplastic Syndrome
por: Schwartz, Jason R., et al.
Publicado: (2017)

Myelodysplastic syndrome transformed into B-lineage acute lymphoblastic leukemia: A case report
por: Zhu, Ye-Jing, et al.
Publicado: (2021)

Acute Myeloid Leukemia with Basophilic Differentiation Transformed from Myelodysplastic Syndrome
por: Tanaka, Yasuhiro, et al.
Publicado: (2017)

SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma
por: Shan, Qingqing, et al.
Publicado: (2023)

C/EBPα: critical at the origin of leukemic transformation
por: Roe, Jae-Seok, et al.
Publicado: (2014)

The Earliest T-Precursors in the Mouse Embryo Are Susceptible to Leukemic Transformation
por: Ding, Jixin, et al.
Publicado: (2021)

Deciphering the Key Pharmacological Pathways and Targets of Yisui Qinghuang Powder That Acts on Myelodysplastic Syndromes Using a Network Pharmacology-Based Strategy
por: Han, Zijian, et al.
Publicado: (2020)

Transformation of a myelodysplastic syndrome to acute myeloid leukemia and concurrent necrotizing sweet syndrome
por: Vera-Lastra, Olga, et al.
Publicado: (2021)

Expression profile of the amino acid transporters SLC7A5, SLC7A7, SLC7A8 and the enzyme TDO2 in basal cell carcinoma
por: Tina, E., et al.
Publicado: (2018)

Targeting age-related inflammation in myelodysplastic syndromes
por: Mei, Yang, et al.
Publicado: (2018)

Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome
por: Lee, Paul, et al.
Publicado: (2021)

Myelodysplastic syndromes
por: Hellström Lindberg, Eva
Publicado: (2018)

GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome
por: Zhou, Jing‐Dong, et al.
Publicado: (2016)

PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features
por: Teye, Emmanuel K., et al.
Publicado: (2017)

Targeted demethylation of the SLC5A7 promotor inhibits colorectal cancer progression
por: Li, Yang, et al.
Publicado: (2022)

A Rare Case of Transformation of Childhood Myelodysplastic Syndrome to Acute Lymphoblastic Leukemia
por: Koh, Young Rae, et al.
Publicado: (2013)

Mapping and targeting of the leukemic microenvironment
por: Witkowski, Matthew T., et al.
Publicado: (2019)

Slc7a5 regulation of neural development
por: Sokolov, Aidan M., et al.
Publicado: (2021)

The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia
por: Tibes, Raoul, et al.
Publicado: (2015)

Secretion of Transforming Growth Factor‐ß by Human Myelogenous Leukemic Cells and Its Possible Role in Proliferation of the Leukemic Cells
por: Komatsu, Keiko, et al.
Publicado: (1989)

The microenvironment in myelodysplastic syndromes: From concept to therapeutic target
por: Raaijmakers, Marc H.G.P.
Publicado: (2018)

The genomic landscape of pediatric myelodysplastic syndromes
por: Schwartz, Jason R., et al.
Publicado: (2017)

Myelofibrotic and leukemic transformation in 2016 WHO-defined Philadelphia-negative myeloproliferative neoplasm
por: Song, Ik-Chan, et al.
Publicado: (2022)

Acute myeloid leukemia cells and MSC-derived exosomes inhibiting transformation in myelodysplastic syndrome
por: Liu, Xiaoli, et al.
Publicado: (2023)

A Child with Psoriasis, Hypogammaglobulinemia, and Monosomy 7-Positive Myelodysplastic Syndrome
por: Özbek, Namık, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o47ifnbch4fn0cncqd2n1pot0d